OriGenes
Artificial Intelligence (AI) Big Data Analytics Machine Learning (ML) Quantum Computing Synthetic Biology Genomics
The Digistain technology enables precise breast cancer risk stratification at a fraction of the cost and turnaround time of standard genomic-based tests. Using a combination of infrared spectroscopy and quantum AI-enabled machine learning algorithms, the model analyses a patient’s tumour biopsy to identify biochemical biomarkers associated with cancer cell proliferation. It then produces a concise, clinician-friendly risk report that supports evidence-based treatment planning for breast cancer patients.
Sector: AI, Healthtech
Country: South Africa, U.K.
Website: https://www.origenes.bio
